Timothy Eisen
Impact in
Papers in
- Genetics 13
- Genetic Associations and Epidemiology 13
-
- Renal cell carcinoma treatment 8
- Lung Cancer Treatments and Mutations 3
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- Richard S. Houlston (5 shared papers)Peter Broderick (5 shared papers)Athena Matakidou (5 shared papers)Yufei Wang (4 shared papers)Jayaram Vijayakrishnan (3 shared papers)Margaret R. Spitz (2 shared papers)Christopher Ian Amos (2 shared papers)Mobshra Qureshi (1 shared paper)
- Journals
- PLoS ONE (3 papers)The American Journal of Human Genetics (2 papers)JNCI Journal of the National Cancer Institute (2 papers)Nature Genetics (2 papers)Carcinogenesis (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Timothy Eisen
24 papers receiving 2.6k citations
Timothy Eisen's Hit Papers
Peers
Comparison fields: 5 of 71
- Genetics 1.4k
- Oncology 527
- Pulmonary and Respiratory Medicine 566
- Cancer Research 165
- Physiology 296
Countries citing papers authored by Timothy Eisen
This map shows the geographic impact of Timothy Eisen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Eisen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Eisen more than expected).
Fields of papers citing papers by Timothy Eisen
This network shows the impact of papers produced by Timothy Eisen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Eisen. The network helps show where Timothy Eisen may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy Eisen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 477 | |
| 2 | 2009 | 448 | |
| 3 | 2011 | 424 | |
| 4 | Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer Hit paper breakdown → | 2014 | 368 |
| 5 | 2012 | 209 | |
| 6 | 2009 | 202 | |
| 7 | 2008 | 132 | |
| 8 | 2010 | 59 | |
| 9 | 2014 | 51 | |
| 10 | 2011 | 47 | |
| 11 | 2017 | 42 | |
| 12 | 2011 | 27 | |
| 13 | 2011 | 24 | |
| 14 | 2015 | 24 | |
| 15 | Phase III randomised comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC) | 2002 | 22 |
| 16 | 2016 | 17 | |
| 17 | 2010 | 15 | |
| 18 | 2015 | 14 | |
| 19 | 2017 | 14 | |
| 20 | 2015 | 8 |
About Timothy Eisen
Timothy Eisen is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Physiology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 2.6k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (13 papers), Renal cell carcinoma treatment (8 papers), Lung Cancer Treatments and Mutations (3 papers), Smoking Behavior and Cessation (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Telomeres, Telomerase, and Senescence (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Genetics (1.4k citations), Oncology (527 citations), Pulmonary and Respiratory Medicine (566 citations), Cancer Research (165 citations) and Physiology (296 citations). Timothy Eisen has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Richard S. Houlston, Peter Broderick, Athena Matakidou, Yufei Wang, Jayaram Vijayakrishnan, Margaret R. Spitz, Christopher Ian Amos, Mobshra Qureshi, Emily L. Webb and Xiangjun Gu. Their work appears in journals such as PLoS ONE, The American Journal of Human Genetics, JNCI Journal of the National Cancer Institute, Nature Genetics and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.